These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19900324)

  • 1. [Primary biliary cirrhosis].
    Kuiper EM; den Ouden-Muller JW; van Buuren HR
    Ned Tijdschr Geneeskd; 2009; 153():A483. PubMed ID: 19900324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.
    Heathcote EJ
    Hepatology; 2000 Apr; 31(4):1005-13. PubMed ID: 10733559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of primary biliary cirrhosis.
    Nishio A; Keeffe EB; Ishibashi H; Gershwin EM
    Med Sci Monit; 2000; 6(1):181-93. PubMed ID: 11208308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation and diagnosis of primary biliary cirrhosis in the 21st century.
    Kumagi T; Onji M
    Clin Liver Dis; 2008 May; 12(2):243-59; vii. PubMed ID: 18456178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary biliary cirrhosis.
    Hohenester S; Oude-Elferink RP; Beuers U
    Semin Immunopathol; 2009 Sep; 31(3):283-307. PubMed ID: 19603170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary biliary cirrhosis: from induction to destruction.
    Nishio A; Bass NM; Luketic VA; Coppel RL; Gershwin ME
    Semin Gastrointest Dis; 2001 Apr; 12(2):89-102. PubMed ID: 11352123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary biliary cirrhosis (PBC) (symptomatic, asymptomatic)].
    Okuaki Y; Toda G
    Ryoikibetsu Shokogun Shirizu; 1995; (7):560-4. PubMed ID: 8749554
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid].
    Wirth HP; Zala G; Meyenberger C; Ammann R
    Schweiz Med Wochenschr; 1995 Apr; 125(15):750-4. PubMed ID: 7740290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary biliary cirrhosis (PBC)].
    Rautiainen H
    Duodecim; 2012; 128(15):1550-9. PubMed ID: 22970606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of primary biliary cirrhosis.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy.
    Lazaridis KN; Talwalkar JA
    J Clin Gastroenterol; 2007; 41(5):494-500. PubMed ID: 17450033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary biliary cirrhosis.
    Dabaghi RE; Lester R
    Am Fam Physician; 1986 May; 33(5):155-65. PubMed ID: 3518374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities in the treatment of primary biliary cirrhosis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Jun; 146(23):1245-9. PubMed ID: 15988919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cirrhosis: when and why does the disease develop?
    Floreani A; Ostuni PA; Ferrara F; Guido M
    Dig Liver Dis; 2006 Apr; 38(4):272-5. PubMed ID: 16567309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pruritus in liver disease: case report with discussion].
    Hug B; Fried R; Terracciano L
    Praxis (Bern 1994); 1998 Dec; 87(51-52):1805-10. PubMed ID: 10025154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.